0001178913-24-000357.txt : 20240205 0001178913-24-000357.hdr.sgml : 20240205 20240205080016 ACCESSION NUMBER: 0001178913-24-000357 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240205 DATE AS OF CHANGE: 20240205 EFFECTIVENESS DATE: 20240205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RedHill Biopharma Ltd. CENTRAL INDEX KEY: 0001553846 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-504349 FILM NUMBER: 24593987 BUSINESS ADDRESS: STREET 1: 21 HA'ARBA'A STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 BUSINESS PHONE: 972-3-541-3131 MAIL ADDRESS: STREET 1: 21 HA'ARBA'A STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 D 1 primary_doc.xml X0708 D LIVE 0001553846 RedHill Biopharma Ltd. 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 972-3-541-3131 ISRAEL None None Corporation true Dror Ben-Asher 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Director Razi Ingber 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Kenneth Reed 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Shmuel Cabilly 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Ofer Tsimchi 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Eric Swenden 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Rick Scruggs 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Director Alla Felder 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Gilead Raday 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Adi Frish 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Guy Goldberg 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Reza Fathi 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Pharmaceuticals $5,000,001 - $25,000,000 06b false 2024-01-25 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS NY NEW YORK TX TEXAS false 10000000 10000000 0 This Form D is being filed in connection with the issuance of warrants to purchase up to 10,000,000 American Depositary Shares ("ADSs") at an exercise price of $1.00 per ADS, each ADS representing 400 ordinary shares, par value NIS 0.01, of the Company false 5 600000 0 The placement agent (or its designees) also received warrants to purchase up to 600,000 ADSs of the Company, at an exercise price of $1.00 per ADS under Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. 0 false RedHill Biopharma Ltd. /s/ Razi Ingber Razi Ingber Chief Financial Officer 2024-02-05